Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
14.32
-1.31 (-8.38%)
May 6, 2025, 3:31 PM EDT - Market open

Mineralys Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
929613354---
Market Cap Growth
73.31%73.31%----
Enterprise Value
730349100---
Last Close Price
15.6312.318.60---
PB Ratio
4.073.201.47---
P/TBV Ratio
4.853.201.47---
Debt / Equity Ratio
------1.25
Quick Ratio
13.5313.5322.5713.652.100.28
Current Ratio
14.0214.0223.7713.982.200.29
Return on Equity (ROE)
-82.24%-82.24%-41.38%-53.00%-1568.96%-
Return on Assets (ROA)
-52.56%-52.56%-28.91%-31.34%-185.60%-
Return on Capital (ROIC)
-55.62%-55.62%-30.45%-34.99%-335.62%-
Earnings Yield
-19.15%-29.02%-20.34%---
FCF Yield
-17.92%-27.16%-22.96%---
Buyback Yield / Dilution
-34.13%-34.13%-600.33%-3.67%-7.64%-
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q